The biochemical effects of Ciprofloxacin, a wide spectrum antibiotic, co-administered with Nicosan, an antisickling phytomedicine was analyzed for their possible drug interaction. Using standard methods for biochemical, haematological and antioxidant assays, our findings showed that Ciprofloxacin administration gave rise to increase in oxidative radical production, whereas Nicosan administration had no observable adverse effect. However, co-administration of both drugs was found to have no deleterious effects on body organs and erythrocytes. This suggests that the presence of Nicosan had a palliative effect on the oxidative free radicals produced as a result of the antibiotic administration.
INTRODUCTION
Ciprofloxacin is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class (Nelson et al., 2007; Kawahara, 1998) . It was first patented in 1983 by Bayer A.G. and subsequently approved by the United States Food and Drug Administration (FDA) in 1987. Ciprofloxacin has 12 FDA-approved human uses and other veterinary uses. It is a second-generation fluoroquinolone antibacterial agent. It acts by interfering with the DNA gyrase that causes DNA to rewind after being copied, which stops DNA and protein synthesis. Ciprofloxacin interacts with other drugs, herbal and natural supplements, and thyroid medications.
Nicosan is a herbal drug produced by Neimeth Pharmaceuticals, Nigeria, from the extracts of Sorghum bicolour leaf, Pterocarpus osun stem, Piper guinense seed and Caryophylli flower. It has been reported to block the polymerisation of hemoglobin S and might therefore reduce the number of sickle cells in the blood. This has been suggested to help to reduce the severity of the sickle cell disease (Iyamu et al., 2002) . Red blood cell sickling involves the polymerisation of hemoglobin S (Desai, 2004) . In this work, the drug interactions of Ciprofloxacin with Nicosan were studied. The aim of the study is to evaluate the biochemical and haematological effects of the co-administration of Ciprofloxacin and Nicosan in vivo using standard methods of assay for liver function, kidney function, haematological parameters and antioxidant enzymes.
Nigerian Institute of Research (NIMR), Yaba, Lagos, Nigeria were used for the study. The animals were kept in a well-ventilated animal house at the annex of the laboratory Animal Centre of the College of Medicine, University of Lagos, and were acclimatized for 14 days before commencement of the study. They were each day fed with standard rabbit chow (Pfizer Feeds, Ibadan, Nigeria Plc.) and water ad libitum.
Administration of drugs
The rats were grouped into experimental and control groups A, B and C as follows: Groups A1, A2, A3, with 6 rats in each. They were dosed orally with different concentrations of only ciprofloxacin according to their body weight for a period of 5 days. A1 was given the under dose (7.22 mg/ml/180 g of rat), A2 was given the normal dose (7.16 mg/ml/195 g of rat) and A3 was given the overdose of (14.35 mg/ml/195 g of rat) of ciprofloxacin. Groups B1 B2 B3 with 6 rats in each, were dosed orally with the manufacturer's recommended 350 mg/kg Nicosan per body weight dose and then immediately followed by a single dose of ciprofloxacin per body weight of different concentrations for a period of 5 days. B1 were given Nicosan with under dose of ciprofloxacin, B2 were given Nicosan and normal dose of ciprofloxacin, B3 were given Nicosan and overdose of ciprofloxacin. Group C with 6 rats were orally administered distilled water (1 ml/body weight) only for a period of 5 days and this set served as the control group.
Collection of blood samples
At the end of the 5 days of drug administration, the rats were euthanized by cervical dislocation and blood samples collected via venipuncture. For the haematological studies ethylenediaminetetraacetic acid (EDTA) bottles were used for the blood collections. For the antioxidant assay, liver function test and kidney function test heparin bottles were used for the blood collection. Standard biochemical, haematological and antioxidant evaluations were then carried out on the collected blood samples.
Biochemical analysis
All biochemical analysis (liver function test, kidney function test, and haematological assay) were all done according to standard protocols using the Roche/Hitachi 902 automated analyzer.
Determination of total protein
This was determined using biuret method (Gonall et al., 1949) .
Antioxidant assay
The antioxidant enzymes activity was determined spectrometrically as follows.
Determination of superoxide dismutase (SOD) activity
Superoxide dismutase activity was determined by its ability to inhibit the auto-oxidation of epinephrine determined in absorbance at 480 nm as described by Sun and Zigma (1978) . The reaction mixture (3 ml) contained 2.95 ml 0.05 M sodium carbonate buffer pH 10.2, 0.02 ml of the serum and 0.03 ml of epinephrine in 0.005 N HCl, was used to initiate the reaction. The reference cuvette 0.02 ml of water. Enzyme activity was calculated by measuring the contained Fatai et al. 2675 2.95 ml buffer, 0.03 ml of substrate (epinephrine) and change in absorbance at 480 nm for 5 min.
Determination of catalase
Serum catalase activity was determined according to previously described methods (Aksenes and Njaa, 1981) by measuring the decrease in absorbance at 240 nm due to the decomposition of H2O2 in a ultra violet (UV) recording spectrophotometer. The reaction mixture (3 ml) contained 0.1 ml of serum in phosphate buffer (50 mM, pH 7.0) and 2.9 of 30 mM H2O2 in phosphate buffer pH 7.0. An extinction coefficient for H2O2 at 240 nm of 40.0 M -1 cm -1 (Aebi, 1984) was used for the calculation. The specific activity of catalase was expressed as moles of H2O2 reduced per minute per mg protein.
Reduced glutathione determination
The reduced glutathione (GSH) content of tissue as non-protein sulphydryls was estimated according to the method described by Sedlak and Lindsay (1960) . To the supernatant, 10% trichloroacetic acid (TCA) was added and centrifuged. 1.0 ml of supernatant was treated with 0.5 ml of Elman's reagent (19.8 mg of 5,5-dithiobisnitro benzoic acid (DTNB) in 100 ml of 0.1% sodium nitrate) and 3.0 ml of phosphate buffer (0.2 M, pH 8.0). The absorbance was read at 412 nm (Nair et al., 1991) .
Lipid peroxidation (MDA)
Malondialdehyde (MDA), an index of lipid peroxidation, was determined using the method of Bluege and Aust (1978) . 1.0 ml of the supernatant was added to 2 ml of (1:1:1 ratio) TCA-TBA-HCL reagent (thiobarbituric acid 0.37%, 0.24 N HCl and 15% TCA) tricarboxylic acid thiobarbituric acin-hydrochloric acid reagent boiled at 100°C for 15 min, and allowed to cool. Flocculent materials were removed by centrifugation at 3000 rpm for 10 min. The supernatant was removed and the absorbance read at 532 nm against a blank. MDA was calculated using the molar extinction coefficient for MDATBA-complex of 1.56 × 10 5 M -1 cm -1 (Torun et al., 2009 ).
Haematological analysis
All haematology analyses (White blood cells, red blood cell, hemoglobin, hemoglobin count, platelet, lymphocyte, neutrophils (%), lymphocytes (%), neutrophils absolute) were performed using standard procedures with the Sysmex automated analyzer (Model:KN-21N).
Statistical analysis
The statistical analysis of the data obtained were analysed using the student t-test and level of significance set at p < 0.05. Table 1 shows a significant increase in the enzyme activities in the liver [aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), total bilirubin (T-BIL)] for groups A1, A2, A3 that *Shows significant difference at p<0.05 for creatinine and urea using student t-test. Group A1: under dose (7.22 mg/ml/180 g of rat), A2: normal dose (7.16 mg/ml/195 g of rat) and A3: overdose of (14.35 mg/ml/195 g of rat) of ciprofloxacin. Group B1: 350 mg Nicosan/kg rat dose and under dose of ciprofloxacin, B2: were given Nicosan and normal dose of ciprofloxacin, B3: were given Nicosan and overdose of ciprofloxacin. Group C: 1 ml distilled water.
RESULTS

Liver function test
were given ciprofloxacin only as compared with the control that were given distilled water only. Groups B1, B2, B3 that were given ciprofloxacin and nicosan did show a significant decrease in the level of these enzyme activities as compared with the control that were given distilled water only. Table 2 shows a significant increase in the level of the indicators of kidney function (that is, creatinine and urea) for groups A1, A2, A3 as compared with the control that were given distilled water only, and for groups B1, B2, B3 showed a significant decrease in the level of the parameters as compared with the control group given distilled water only. Table 3 shows a significant increase in the level of protein (total protein and albumin) and lipid profile (CHOL, TG) for groups A1, A2, A3 as compared with the control that were given distilled water only, while groups B1, B2, B3 showed a significant decrease in the level of the protein and lipid profile as compared with the controls that were given distilled water only. Table 4 shows a significant increase in the level of the antioxidant enzyme activities (SOD, GSH, catalase (CAT), MDA) in the serum for groups A1, A2, A3 and also for groups B1, B2, B3 as compared with the control that were given distilled water only. Table 5 shows a significant increase in the level of the haematological parameters (RBC, HB, PLT, HCT) in the blood for groups A1, A2, A3 as compared with the control that were given distilled water only and also a significant increase was also observed in these parameters for groups B1, B2, B3 as compared with the control that were given distilled water only. Table 6 shows a significant increase in the level of the other haematological (LYMP, NEUT (%), LYMP (%), NEUTABS) parameters in the blood for groups A1, A2, A3 as compared with the control that were given distilled water only while groups B1, B2, B3 showed a significant decrease in the level of these parameters as compared with the control that were given distilled water only.
Kidney function test
Total lipid and total protein test results
Antioxidant assay result
Haematological assay result
DISCUSSION
Ciprofloxacin inhibits an enzyme called DNA gyrase that *Shows a significant drug interaction at p < 0.05 for TG, CHOL, ALB, and TP, using student t-test. Group A1: under dose (7.22 mg/ml/180 g of rat), A2: normal dose (7.16 mg/ml/195 g of rat) and A3: overdose of (14.35 mg/ml/195 g of rat) of ciprofloxacin. Group B1: 350 mg Nicosan/kg rat dose and under dose of ciprofloxacin, B2: were given Nicosan and normal dose of ciprofloxacin, B3: were given Nicosan and overdose of ciprofloxacin. Group C: 1 ml distilled water. *Shows a significant difference at p < 0.05 for CAT, GSH, SOD and MDA, using student t-test. Group A1: under dose (7.22 mg/ml/180 g of rat), A2: normal dose (7.16 mg/ml/195 g of rat) and A3: overdose of (14.35 mg/ml/195 g of rat) of ciprofloxacin. Group B1: 350 mg Nicosan/kg rat dose and under dose of ciprofloxacin, B2: were given Nicosan and normal dose of ciprofloxacin, B3: were given Nicosan and overdose of ciprofloxacin. Group C: 1 ml distilled water. *p < 0.05 Shows significant difference due to drug interaction. Group A1: under dose (7.22 mg/ml/180 g of rat), A2: normal dose (7.16 mg/ml/195 g of rat) and A3: overdose of (14.35 mg/ml/195 g of rat) of ciprofloxacin. Group B1: 350 mg Nicosan/kg rat dose and under dose of ciprofloxacin, B2: were given Nicosan and normal dose of ciprofloxacin, B3: were given Nicosan and overdose of ciprofloxacin. Group C: 1 ml distilled water. *At p<0.05 shows a significant difference due to drug interaction. Group A1: under dose (7.22 mg/ml/180 g of rat), A2: normal dose (7.16 mg/ml/195 g of rat) and A3: overdose of (14.35 mg/ml/195 g of rat) of ciprofloxacin. Group B1: 350 mg Nicosan/kg rat dose and under dose of ciprofloxacin, B2: were given Nicosan and normal dose of ciprofloxacin, B3: were given Nicosan and overdose of ciprofloxacin. Group C: 1 ml distilled water.
is an essential component of the mechanism that passes genetic information onto daughter cells when a cell divides. Ciprofloxacin is eliminated primarily by renal excretion; however, the drug is also metabolized and partially cleared through the biliary system of the liver and through the intestine. Over dose of ciprofloxacin can lead to acute renal toxicity and death (Fuchs et al., 1994) . Nicosan on the other hand is a phytochemical used for the treatment of sickle cell disease, without any reported adverse effects at recommended doses (Iyamu et al., 2002) . Our present study has shown the effects of the antibacterial drug, ciprofloxacin on the antioxidant status in vivo and the counter effect noticed in co-administration with Nicosan. Antioxidant enzymes such as SOD, GSH, CAT and MDH help in scavenging free radicals released into the blood due to some oxidative stress activities (Matés et al., 1999) . These antioxidant enzymes metabolizes oxidative toxic intermediate. The levels of these enzymes measured in our study were quite noteworthy. The effect of the co administration of ciprofloxacin and nicosan for the groups B1, B2, B3 (Ciprox + Nicosan) did not show any statistically significant drug interaction at p < 0.05 which suggest that there was no oxidative damage to the cells unlike the elevation of the antioxidant enzymes observed in group A 3 (ciprofloxacin only), where there was a significant drug interaction (p < 0.05) in the level of the catalase, GSH, MDA, SOD and total protein as compared with the control. This stability in antioxidant enzyme levels may be as a result of the presence of the antioxidant properties of some of the constituents of Nicosan that is, Pterocarpus osun stem and Eugenia caryophyllus fruit, which might have helped in neutralizing the effect ciprofloxacin including the case of the overdose of ciprofloxacin in group B 3.
In the kidney function test, the increased level in the values of the two marker enzymes, creatinine and urea in groups A1, A2, A3 signifies a liver disorder or damage (Rule et a., 2004) as compared with the control group C which has a normal range of values of these marker enzymes, but in groups B1, B2, B3, there was a statistical decrease in the values of creatinine and urea which does not signify any liver damage and could be due to the coadministration of nicosan with ciprofloxacin which helped in reducing the risk of kidney damage that might have occurred due to the administration of ciprofloxacin.
In the case of liver function test, the statistical increase in the level of the marker enzymes that is, AST, ALT, ALP, T.BIL in groups A1, A2, A3, signifies possible liver damage (Lee, 2009) as compared with the control group C which has a normal range of values of these marker enzymes, while a decrease in the level of the enzymes in group B1, B2, B3 signifies that the liver is in good order even with use of overdose of ciprofloxacin. This could also be due to the co-administration of nicosan and ciprofloxacin.
From the statistical increase in the values of the total lipid and total protein, TG, CHOL, albumin and TP in groups A1, A2, A3, as compared with the control group C which has a normal range of values of parameters, these could signify a high risk of heart disease or blood vessel disease. But in groups B1, B2, B3, the statistical decrease in the values of these parameters signifies a low risk of heart disease or blood vessel disease and these could also be due to the co-administration of nicosan and ciprofloxacin. In the haematological studies, the statistical increase in the level of the parameters that is, RBC, Hob, PLT, HCT, LYMP, NEU (%), LYMP (%), NEUTABS in group A1, A2, A3 signifies the presence of a blood disease as compared with the control group C which has a normal range of values of parameters, while in group B1, B2, B3 the statistically decrease in the level of these parameters signifies that the blood is in its right state.
Therefore, due to the potential toxicity effect of ciprofloxacin, the co-administration of ciprofloxacin with Nicosan may be beneficial as it has been shown in this study, to confer on the host some level of erythrocyte membrane protection against drug-induced oxidative stress. This is probably due to the constituents of Nicosan which have antioxidant and blood-boosting activities that might have suppressed the oxidative stress and cell lysis that could arise by taking the different ciprofloxacin doses.
Conclusion
From the results of our study, co-administration of ciprofloxacin and Nicosan did not show any adverse effects of drug-drug interactions. Therefore the use of ciprofloxacin can be made safer (or adverse effects of the antibiotic can be reduced) by the deliberate administration of nicosan. ABBREVIATIONS ALB, Albumin; ALP, alkaline phosphatise; ALT, alanine amino transferase; CAT, catalase; CHOL, cholesterol; CREAT, creatinine; GSH, glutathione, reduced form; GSSG, glutathione, oxidized form; HB, haemoglobin; HCT, haemoglobin count; LYMP, lymphocytes; MDA, malonaldehyde; NEUT, neutrophils; PLT, platelet; RBC, red blood cell; SOD, superoxide dismutase; TG, triglyceride; TP, total protein; WBC, white blood cell.
